ASCENSIA DIABETES CARE PROUDLY SUPPORTS SPARE A ROSE CAMPAIGN FOR
FIFTH CONSECUTIVE YEAR
Ascensia Diabetes Care, a global diabetes care company, makers of CONTOUR® blood glucose monitoring (BGM) system portfolio and distributors of the Eversense® continuous glucose monitoring (CGM) system, announces that it will be supporting the Spare a Rose campaign for the fifth consecutive year.
Spare a Rose is a flagship campaign, organized by members of the diabetes community, which raises funds every year to benefit a diabetes related charity. The campaign encourages people to donate the money that they would otherwise spend on a rose on Valentine’s day to charity. Through donations as little as $5, Spare a Rose has previously raised almost $400,000 for its former charity partner, Life for a Child. This year, the campaign’s beneficiary will be Insulin for Life, who provide insulin, supplies, education and advocacy to help save the lives of people with diabetes in disadvantaged regions. The charity accomplishes these goals by providing insulin, diabetes supplies and education to those in need. To date, Insulin for Life has sent supplies to over 74 countries around the world.
Chris Aldred, a diabetes advocate and blogger, said, “The success of previous campaigns and the help of corporate partners like Ascensia have saved the lives of thousands of children and young people in underserved countries. Life for a Child supports children up to 26 years old but young adults have the same needs. That’s why this year, as a community, we decided to direct donations from the Spare a Rose campaign to Insulin for Life to extend our support to them too.”
Ascensia is encouraging its 1500 employees to donate to Spare a Rose and has committed to matching their donations up to one rose, or $5, per employee, plus an initial $5,000 donation. Ascensia and its employees are one of the largest fundraisers for this campaign to date, having raised a total exceeding $56,000 over the past few years.
Robert Schumm, President at Ascensia Diabetes Care, said, “The Spare a Rose campaign was created by the diabetes community, for the diabetes community, and we are incredibly proud to support it for the fifth year in a row. At Ascensia, it’s hugely important for us to support the global diabetes community and actively live our value ‘Only Diabetes’. I am always impressed with the generosity and enthusiasm of our employees that surrounds this initiative.”
He added, “The campaign has played an essential role in saving the lives of children and young adults with diabetes around the world. We are pleased to see the campaign will now benefit adults with diabetes through Insulin for Life after witnessing the difference it was able to make in the past. Over the past few years, crucial supplies were delivered to children living with diabetes in countries with significant need thanks to this campaign and its organizers. I encourage both our Ascensia colleagues as well as and people outside of our organization to donate what they can to this worthwhile cause.”
Donations to Spare a Rose can be made at https://sparearose.org/.
Notes for Editors
About Ascensia Diabetes Care
Ascensia Diabetes Care is a global company focused entirely on helping people with diabetes. Our mission is to empower those living with diabetes through innovative solutions that simplify and improve their lives.
We are home to the world-renowned CONTOUR® portfolio of blood glucose monitoring systems and the exclusive global distribution partner for the Eversense® continuous glucose monitoring systems from Senseonics. These products combine advanced technology with user-friendly functionality to help people with diabetes manage their condition and make a positive difference to their lives. As a trusted partner in the diabetes community, we collaborate closely with healthcare professionals and other partners to ensure our products meet the highest standards of accuracy, precision and reliability, and that we conduct our business compliantly and with integrity.
Ascensia is a member of PHC Group and was established in 2016 through the acquisition of Bayer Diabetes Care by PHC Holdings Corporation (formerly Panasonic Healthcare). Ascensia products are sold in more than 125 countries. Ascensia has around 1,500 employees and operations in 31 countries.
For further information, please visit the Ascensia Diabetes Care website at: http://www.ascensia.com
©2022 Ascensia Diabetes Care Holdings AG. All right reserved. Ascensia, the Ascensia Diabetes Care logo and Contour are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG.
For more media enquiries, please contact:
Tim Stamper, Timothy.Stamper@Ascensia.com